WVP
LJPC

Worth Venture Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Worth Venture Partners’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-85,425
Closed -$358K – 151
2020
Q1 		$358K Buy
85,425
+53,927
+171% +$341K 0.22% 60
2019
Q4 		$124K Sell
31,498
-17,802
-36% -$105K 0.06% 73
2019
Q3 		$434K Buy
49,300
+27,300
+124% +$258K 0.25% 48
2019
Q2 		$204K Sell
22,000
-73,607
-77% -$555K 0.11% 67
2019
Q1 		$615K Buy
+95,607
New +$623K 0.34% 41

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Worth Venture Partners's LJPC Position: Q2 2020 in Review

Worth Venture Partners sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 85,425 shares — an estimated $358K sold.

Worth Venture Partners first reported a position in LJPC in Q1 2019 and held it in 5 quarters. The position peaked at $615K in Q1 2019. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Worth Venture Partners reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Worth Venture Partners sold 85,425 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $358K.
  • Worth Venture Partners first reported a position in La Jolla Pharmaceutical Company in Q1 2019 and held it in 5 quarters.
  • Worth Venture Partners's La Jolla Pharmaceutical Company position peaked at $615K in Q1 2019.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.